Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001451612-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
22
Total Shares
285,684
Total Value
$34,812,908.93
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 25, 2026 | Sale | 37,179 | $119.71 | $4,450,698.09 | 3,075,906 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 112,299 | $120.66 | $13,549,997.34 | 2,963,607 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 40,774 | $121.38 | $4,949,148.12 | 2,922,833 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 4,977 | $122.67 | $610,528.59 | 2,917,856 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 10,860 | $123.62 | $1,342,513.20 | 2,906,996 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 11,711 | $124.61 | $1,459,307.71 | 2,895,285 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 3,716 | $125.82 | $467,547.12 | 2,891,569 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 1,609 | $126.71 | $203,876.39 | 2,889,960 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 25,075 | $127.37 | $3,193,802.75 | 2,864,885 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 2,197 | $128.69 | $282,731.93 | 2,862,688 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 337 | $129.61 | $43,678.57 | 2,862,351 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 5,144 | $119.71 | $615,788.24 | 559,524 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 15,660 | $120.66 | $1,889,535.60 | 543,864 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 5,689 | $121.38 | $690,530.82 | 538,175 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 698 | $122.67 | $85,623.66 | 537,477 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 1,517 | $123.62 | $187,531.54 | 535,960 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 1,639 | $124.61 | $204,235.79 | 534,321 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 522 | $125.82 | $65,678.04 | 533,799 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 223 | $126.71 | $28,256.33 | 533,576 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 3,507 | $127.37 | $446,686.59 | 530,069 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 305 | $128.69 | $39,250.45 | 529,764 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Jun 25, 2026 | Sale | 46 | $129.61 | $5,962.06 | 529,718 | Indirect | See footnote | View Details |